Functional impairment and cues for rehabilitation of head and neck cancer patients -

Page 146 - Functional impairment and cues for rehabilitation of head and neck cancer patients -

P. 146

144
Chapter 5
REFERENCES
1. Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013;31(36):4550-9.
2. Kreeft A,Tan IB, van den Brekel MW, Hilgers FJ, Balm AJ.The surgical dilemma of‘functional inoperability’in oral and oropharyngeal cancer: current consensus on operability with regard to functional results. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery. 2009;34(2):140-6.
3. Lazarus C, Logemann JA, Pauloski BR, Rademaker AW, Helenowski IB, Vonesh EF, et al. Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer. Head Neck. 2007;29(7):632-7.
4. Hutcheson KA, Lewin JS, Barringer DA, Lisec A, Gunn GB, Moore MW, et al. Late dysphagia after radiotherapy-based treatment of head and neck cancer. Cancer. 2012;118(23):5793-9.
5. Mehanna H, Robinson M, Hartley A, Kong A, Foran B, Fulton-Lieuw T, et al. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial. Lancet (London, England). 2019;393(10166):51-60.
6. Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, et al. Radiotherapy plus cetuximab or cisplatin in human papillomavirus- positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet (London, England). 2019;393(10166):40-50.
7. Wall LR, Ward EC, Cartmill B, Hill AJ. Physiological changes to the swallowing mechanism following (chemo)radiotherapy for head and neck cancer: a systematic review. Dysphagia. 2013;28(4):481-93.
8. Grant S, Kamal M, Mohamed ASR, Zaveri J, Barrow MP, Gunn GB, et al. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing. Cancer. 2019;125(10):1654-64.
9. Starmer HM, Tippett D, Webster K, Quon H, Jones B, Hardy S, et al. Swallowing outcomes in patients with oropharyngeal cancer undergoing organ- preservation treatment. Head Neck. 2014;36(10):1392-7.
10. Hunter KU, Schipper M, Feng FY, Lyden T, Haxer M, Murdoch-Kinch CA, et al. Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes. International journal of radiation oncology, biology, physics. 2013;85(4):935-40.
11. van der Molen L, Heemsbergen WD, de Jong R, van Rossum MA, Smeele LE, Rasch CR, et al. Dysphagia and trismus after concomitant chemo- Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures. Radiother Oncol. 2013;106(3):364-9.
12. Lindblom U, Garskog O, Kjellen E, Laurell G, Levring Jaghagen E, Wahlberg P, et al. Radiation-induced trismus in the ARTSCAN head and neck trial. Acta oncologica (Stockholm, Sweden). 2014;53(5):620-7.
13. van der Geer SJ, Kamstra JI, Roodenburg JL, van Leeuwen M, Reintsema H, Langendijk JA, et al. Predictors for trismus in patients receiving radiotherapy. Acta oncologica (Stockholm, Sweden). 2016;55(11):1318-23.
14. van der Geer SJ, van Rijn PV, Kamstra JI, Langendijk JA, van der Laan B, Roodenburg JLN, et al. Prevalence and prediction of trismus in patients with head and neck cancer: A cross-sectional study. Head Neck. 2019;41(1):64-71.
15. Watters AL, Cope S, Keller MN, Padilla M, Enciso R. Prevalence of trismus in patients with head and neck cancer: A systematic review with meta- analysis. Head Neck. 2019;41(9):3408-21.
16. Kraaijenga SA, Hamming-Vrieze O, Verheijen S, Lamers E, van der Molen L, Hilgers FJ, et al. Radiation dose to the masseter and medial pterygoid muscle in relation to trismus after chemoradiotherapy for advanced head and neck cancer. Head Neck. 2019;41(5):1387-94.
17. Van den Steen L, Van Gestel D, Vanderveken O, Vanderwegen J, Lazarus C, Daisne JF, et al. Evolution of self-perceived swallowing function, tongue strength and swallow-related quality of life during radiotherapy in head and neck cancer patients. Head Neck. 2019;41(7):2197-207.
18. Balm AJ, Rasch CR, Schornagel JH, Hilgers FJ, Keus RB, Schultze-Kool L, et al. High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. Head Neck. 2004;26(6):485-93.
19. Ackerstaff AH, Balm AJ, Rasch CR, de Boer JP, Wiggenraad R, Rietveld DH, et al. First-year quality of life assessment of an intra-arterial (RADPLAT) versus intravenous chemoradiation phase III trial. Head Neck. 2009;31(1):77-84.
20. Karsten RT, Al-Mamgani A, Bril SI, Tjon AJS, van der Molen L, de Boer JP, et al. Sarcopenia, a strong determinant for prolonged feeding tube dependency after chemoradiotherapy for head and neck cancer. Head Neck. 2019;41(11):4000-8.
21. Olson B, Edwards J, Stone L, Jiang A, Zhu X, Holland J, et al. Association of Sarcopenia With Oncologic Outcomes of Primary Surgery or Definitive Radiotherapy Among Patients With Localized Oropharyngeal Squamous Cell Carcinoma. JAMA otolaryngology-- head & neck surgery. 2020.
22. Passchier E, Stuiver MM, van der Molen L, Kerkhof SI, van den Brekel MW, Hilgers FJ. Feasibility and impact of a dedicated multidisciplinary rehabilitation program on health-related quality of life in advanced head and neck cancer patients. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino- Laryngology - Head and Neck Surgery. 2016;273(6):1577-87.
23. van der Molen L, van Rossum MA, Burkhead LM, Smeele LE, Rasch CR, Hilgers FJ. A randomized preventive rehabilitation trial in advanced head and neck cancer patients treated with chemoradiotherapy: feasibility, compliance, and short-term effects. Dysphagia. 2011;26(2):155-70.
24. Swartz JE, Pothen AJ, Wegner I, Smid EJ, Swart KM, de Bree R, et al. Feasibility of using head and neck CT imaging to assess skeletal muscle mass
in head and neck cancer patients. Oral Oncol. 2016;62:28-33.

144 145 146 147 148